Efficacy of zoledronic acid treatment in Paget disease of bone
Articles > Article · 2014
Authors: E. K. BAYKAN, Lütfiye Füsun SAYGILI, Mehmet ERDOĞAN, Şevki ÇETİNKALP, Ahmet Gökhan ÖZGEN, CENGİZ YILMAZ
OSTEOPOROSIS INTERNATIONAL, Journal Indexed in SCI Expanded, International, WoS, 2014, vol 25, pp 2221-2223
DOI: 10.1007/s00198-014-2752-z
Summary
Clinical trials have shown that zoledronic acid was more effective than other bisphosphonates in the treatment of Paget disease. We retrospectively reviewed remission and relapse statuses of 12 patients with Paget disease. Remission was achieved in all patients after treatment. We recommend zoledronic acid in the first-line treatment of Paget disease.